US2005266441A1PendingUtilityA1
Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids
Est. expiryFeb 19, 2012(expired)· nominal 20-yr term from priority
B01J 2219/00313C12Q 1/6834B01J 2219/00596B82Y 30/00B01J 2219/00585B01J 2219/00612B01J 2219/00617B01J 2219/00662C12Q 1/6811C12Q 1/6853B01J 2219/00621B01J 2219/00675B01J 2219/00608B01J 2219/00644C40B 50/14B01J 2219/00315B01J 2219/00283Y10S435/81B01J 2219/00659Y10S436/808B01J 2219/0061B01J 2219/00527B01J 2219/00605C12Q 1/686B01J 19/0046B01J 2219/00626C12Q 1/6874B01J 2219/00529C12Q 1/6806C12N 15/10B01J 2219/00637C40B 40/06C40B 60/14B01J 2219/00722C12Q 1/6837
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides hyperactive mutant recombinases and hybrid mutant recombinases, and methods for their identification. Also provided are nucleic acids encoding hyperactive mutant recombinases and hybrid recombinases, as well as vectors and host cells. Host cells include eukaryotic cells capable of expressing said recombinases and carrying out site-specific recombination in the cell. The mutant recombinases may be used, for example, in biotechnology, gene therapy or transgenic applications.
Claims
exact text as granted — not AI-modified1 - 159 . (canceled)
160 . A composition comprising at least two oligonucleotides complementary to unique sequences of interest in a DNA sample, and an amplified mixture of DNA isolated from a genome, wherein the amplified mixture of DNA is made by cleaving a genomic DNA sample with a restriction enzyme, thereby providing restriction fragments;
ligating linker nucleic acids to the DNA restriction fragments; providing oligomers that are complementary to the linker nucleic acids; and, amplifying the linked DNA by the polymerase chain reaction using the oligomers as primers, thereby providing the amplified mixture of DNA.
161 . The composition of claim 160 , wherein the at least two oligonucleotides are immobilized on a solid substrate.
162 . A method of characterizing a nucleic acid, comprising:
providing at least one oligonucleotide which is complementary to a unique sequence of interest in a genomic DNA sample; amplifying a mixture of nucleic acids comprising a group of genome fragments, thereby providing an amplified nucleic acid mixture of genome fragments; and hybridizing the at least one oligonucleotide to the amplified nucleic acid mixture, thereby detecting at least one nucleic acid of interest in said amplified mixture.
163 . The method of claim 162 , wherein the oligonucleotide is a member of an array of oligonucleotides, which array comprises additional oligonucleotides which hybridize to unique genomic sequences of interest.
164 . The method of claim 162 , wherein the amplified nucleic acid mixture is made by cleaving a genomic DNA sample with a restriction enzyme, thereby providing restriction fragments;
ligating linker nucleic acids to the DNA restriction fragments; providing oligomers that are complementary to the linker nucleic acids; and, amplifying the linked DNA by the polymerase chain reaction using the oligomers as primers, thereby providing the amplified nucleic acid mixture.Join the waitlist — get patent alerts
Track US2005266441A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.